Ann: AGM Chair's address and CEO's presentation, page-3

I almost spat out my coffee reading the chairman’s address when he said recent updates about failures including the AZD0466 program with AstraZeneca would not change the trajectory of the company.
What planet is he on?? Starpharma told us on numerous occasions that the AstraZeneca deal was worth approximately one billion dollars over the duration of the deal. But that possible cash flow disappeared last year.

But here’s the kicker. Until 10 minutes ago shareholders had been led to believe that the overall partnership with AstraZeneca was still on foot. Until I saw this in today’s AGM presentation. Apparently and by extreme happenstance, the agreement was terminated last night. Just wow !!